Development of targeted alpha particle therapy for solid tumors.

Tafreshi, Narges K., Doligalski, Michael L., Tichacek, Christopher J., Pandya, Darpan N., Budzevich, Mikalai M., El-Haddad, Ghassan, Khushalani, Nikhil I., Moros, Eduardo G. +3 more·2019·Molecules
DOI 10.3390/molecules24234314

Cites (283)

Items 201–266 of 266

  1. The potential for Cerenkov luminescence imaging of alpha-emitting radionuclides
    Nicole L. Ackerman, Edward Elliot Graves · 2012 · Physics in Medicine and Biology
  2. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, Holger J. Jensen, Börje Karlsson, Sture Lindegren, Elisabet Warnhammar, Lars Jacobsson · 2005 · PubMed
  3. Targeted alpha anticancer therapies: update and future prospects
    Barry Allen, Chen‐Yu Huang, Raymond A. Clarke · 2014 · Biologics
  4. Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate
    Ho Sze Chan, Mark Konijnenberg, Erik de Blois, Stuart J. Koelewijn, Richard Paul Baum, Alfred Morgenstern, Frank Bruchertseifer, Wouter A.P. Breeman, Marion de Jong · 2016 · EJNMMI Research
  5. Cerenkov Luminescence Imaging for Radiation Dose Calculation of a 90Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist
    Christian Lohrmann, Hanwen Zhang, Daniel L.J. Thorek, Pooja Desai, PAT B. ZANZONICO, Joseph A. O’Donoghue, Christopher P. Irwin, Thomas Reiner, Jan Grimm, Wolfgang Weber · 2015 · Journal of Nuclear Medicine
  6. A Phase I Study of Samarium Lexidronam/Bortezomib Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma
    James R. Berenson, Ori Yellin, Ravi Patel, Herb Duvivier, Youram Nassir, Russell Mapes, Christina DiLauro Abaya, Regina A. Swift · 2009 · Clinical Cancer Research
  7. Encapsulation of α-Particle–Emitting225Ac3+Ions Within Carbon Nanotubes
    Michael L. Matson, Carlos H. Villa, Jeyarama S. Ananta, Justin J. Law, David A. Scheinberg, Lon J. Wilson · 2015 · Journal of Nuclear Medicine
  8. Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
    Jessie R. Nedrow, Anders Josefsson, Sunju Park, Tom A. Bäck, Robert F. Hobbs, Cory F. Brayton, Frank Bruchertseifer, Alfred Morgenstern, George Sgouros · 2017 · EJNMMI Research
  9. Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab
    Jostein Dahle, Thora J. Jónasdóttir, Helèn Heyerdahl, Jahn Martin Nesland, Jørgen Borrebæk, Anne Kristine Hjelmerud, Roy H. Larsen · 2009 · European Journal of Nuclear Medicine and Molecular Imaging
  10. The Curative and Palliative Potential of the Monoclonal Antibody MOv18 Labelled with211At in Nude Mice with Intraperitoneally growing Ovarian Cancer Xenografts - A Long-Term Study
    Håkan Andersson, Sture Lindegren, Tom Bäc · 2000 · Acta Oncologica
  11. Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease
    Diane E. Milenic, Kwamena E. Baidoo, Young‐Seung Kim, Martin W. Brechbiel · 2015 · mAbs
  12. Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3–Targeted Liposomes
    Anirudh Sattiraju, Xiao-Bing Xiong, Darpan N. Pandya, Thaddeus J. Wadas, Ang Xuan, Yao Sun, Youngkyoo Jung, Kiran Kumar Solingapuram Sai, Jay F. Dorsey, King C. Li et al. · 2017 · Molecular Cancer Therapeutics
  13. Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1
    Meili Zhang, Zhengsheng Yao, Hiral J. Patel, Kayhan Garmestani, Zhuo Zhang, Vladimir S. Talanov, Paul S. Plascjak, Carolyn K. Goldman, John Edward Janik, Martin W. Brechbiel et al. · 2007 · Proceedings of the National Academy of Sciences
  14. Integrin Targeted Imaging and Therapy
    Xiaoyuan Chen · 2011 · Theranostics
  15. 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
    Benjamin B. Kasten, Patsy G. Oliver, Harrison Kim, Jinda Fan, Soldano Ferrone, Kurt R. Zinn, Donald J. Buchsbaum · 2018 · International Journal of Molecular Sciences
  16. Improvement of Radioimmunotherapy Using Pretargeting
    Éric Frampas, Caroline Rousseau, Caroline Bodet‐Milin, Jacques Barbet, Jean‐François Chatal, Françoise Kraeber‐Bodéré · 2013 · Frontiers in Oncology
  17. Radium and other alpha emitters in prostate cancer
    Oliver A. Sartor, Deepali Sharma · 2018 · Translational Andrology and Urology
  18. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice
    Ann-Charlott Steffen, Ylva Almqvist, Ming‐Kuan Chyan, Hans Lundqvist, Толмачев Владимир Максимилианович, D. Scott Wilbur, Jörgen Carlsson · 2007 · Oncology Reports
  19. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer
    Hossein Jadvar, SUDHA CHALLA, David I. Quinn, Peter S. Conti · 2015 · Cancer Biotherapy and Radiopharmaceuticals
  20. 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi
    Christof Seidl, Christine Zöckler, Roswitha Beck, Leticia Quintanilla‐Martínez, Frank Bruchertseifer, Reingard Senekowitsch–Schmidtke · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
  21. Radioimmunotherapy for Treatment of Acute Leukemia
    Caroline Bodet‐Milin, Françoise Kraeber‐Bodéré, Thomas Eugène, François Guérard, Joëlle Gaschet, Clément Bailly, Marie Mougin‐Degraef, Mickaël Bourgeois, Alain Faivre-Chauvet, Michel Chérel et al. · 2016 · Seminars in Nuclear Medicine
  22. Bystander signaling via oxidative metabolism
    Humaira Aziz Sawal, Kashif Asghar, Matthias Bureik, Nasir Jalal · 2017 · OncoTargets and Therapy
  23. Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse-Type Gastric Cancer Using a 213Bi-Conjugated Monoclonal Antibody
    Stefanie Bloechl, Roswitha Beck, Christof Seidl, Alfred Morgenstern, Markus Schwaiger, Reingard Senekowitsch–Schmidtke · 2005 · Clinical Cancer Research
  24. Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues
    Charles Zhu, Amey Bandekar, Michelle Sempkowski, Sangeeta Ray Banerjee, Martin G. Pomper, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou · 2015 · Molecular Cancer Therapeutics
  25. Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
    Sébastien Gouard, Amandine Pallardy, Joëlle Gaschet, Alain Faivre-Chauvet, Frank Bruchertseifer, A. Morgenstern, Catherine Maurel, Etienne Matous, Françoise Kraeber‐Bodéré, François Davodeau et al. · 2014 · Nuclear Medicine and Biology
  26. Renal Brush Border Enzyme-Cleavable Linkages for Low Renal Radioactivity Levels of Radiolabeled Antibody Fragments
    Hiromichi Akizawa, Mitsuo Imajima, Hirofumi Hanaoka, Tomoya Uehara, Satoshi Satake, Yasushi Arano · 2013 · Bioconjugate Chemistry
  27. Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a 177 Lu-Labeled Peptide
    Catharina M. van Rij, Cathelijne Frielink, David M. Goldenberg, Robert M. Sharkey, Susanne Lütje, William J. McBride, Wim J.G. Oyen, Otto C. Boerman · 2014 · Cancer Biotherapy and Radiopharmaceuticals
  28. Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific 64Cu-DOTA conjugation
    Richard Tavaré, Wen-Jun Wu, Kirstin A. Zettlitz, Felix B. Salazar, Katelyn E. McCabe, James D. Marks, Anna M. Wu · 2014 · Protein Engineering Design and Selection
  29. Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone
    Amol Madan Takalkar, Scott Adams, Vivek Subbiah · 2014 · Experimental Hematology and Oncology
  30. eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer
    Neal D. Shore, Ronald F. Tutrone Jr., Neil F. Mariados, Luke T. Nordquist, Bryan Allyn Mehlhaff, Karyn J. Steere, Stacey S. Harrelson · 2017 · Clinical Genitourinary Cancer
  31. Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma
    Mengshi Li, Dijie Liu, Dongyoul Lee, Somya Kapoor, Katherine Nicole Gibson-Corley, Thomas P. Quinn, Edwin A. Sagastume, Sarah L. Mott, Susan A. Walsh, Michael R. Acevedo et al. · 2019 · Molecular Pharmaceutics
  32. Description of the Properties of Unattached 218Po and 212Pb Particles by Means of the Classical Theory of Cluster Formation
    Frank Raes · 1985 · Health Physics
  33. Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Sara Westrøm, Tina Bjørnlund Bønsdorff, Øyvind Sverre Bruland, Roy H. Larsen · 2018 · Translational Oncology
  34. 223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
    Dizdarevic, Sabina, Jessop, Maryam, Begley, Patrick, Main, Sean, Robinson, Angus · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
  35. Repeated Intraperitoneal -Radioimmunotherapy of Ovarian Cancer in Mice
    Jörgen Elgqvist, Håkan Andersson, Holger J. Jensen, Helena Kahu, Sture Lindegren, Elisabet Warnhammar, Ragnar Hultborn · 2009 · Journal of Oncology
  36. Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?
    Sally W. Schwarz, Clemens Decristoforo, Anne E. Goodbody, Nikhita Singhal, Sarah Saliba, Patrick S. Ruddock, Katherine Zukotynski, Andrew A. Ross · 2018 · Journal of Nuclear Medicine
  37. Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates
    Yong Li, Emma YanJun Song, Syed Monem Rizvi, Carl Andrew Power, Julia Beretov, Chand Raja, Paul J. Cozzi, Alfred Morgenstern, Christos Apostolidis, Barry Allen et al. · 2009 · Clinical Cancer Research
  38. In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases
    Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer, Frank Rösch · 2018 · Current Radiopharmaceuticals
  39. Fractionated intravesical radioimmunotherapy with213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma
    Julia Fazel, Silvia Rötzer, Christof Seidl, Benedikt Feuerecker, Michael E. Autenrieth, Gregor Weirich, Frank Bruchertseifer, Alfred Morgenstern, Reingard Senekowitsch–Schmidtke · 2015 · Cancer Biology & Therapy
  40. Mechanism of radiation-induced strand break formation in DNA and polynucleotides
    D. Schulte‐Frohlinde · 1986 · Advances in Space Research
  41. Alpha Particle Emitter Radiolabeled Antibody for Metastatic Cancer: What Can We Learn from Heavy Ion Beam Radiobiology?
    Song Hong, Srinivasan Senthamizhchelvan, Robert F. Hobbs, George Sgouros · 2012 · Antibodies
  42. Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives
    Maarten Johannes van der Doelen, Niven Mehra, Rick Hermsen, Marcel J. R. Janssen, Winald R. Gerritsen, Inge M. van Oort · 2018 · Clinical Genitourinary Cancer
  43. The in vivo generator for radioimmunotherapy
    L.F. Mausner, Rita F. Straub, S.C. Srivastava · 1989 · Journal of Labelled Compounds and Radiopharmaceuticals
  44. Structure and properties of DOTA-chelated radiopharmaceuticals within the 225 Ac decay pathway
    Artem R. Khabibullin, Aleksandra M. Karolak, Mikalai M. Budzevich, Mark L. McLaughlin, David L. Morse, Lilia M. Woods · 2018 · MedChemComm
  45. Mutation and Inactivation of Cultured Mammalian Cells Exposed to Beams of Accelerated Heavy Ions
    R.J. Munson, D.A. Bance, Albert Stretch, DUDLEY T. GOODHEAD · 1979 · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine
  46. The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic
    Mehran Makvandi, Brian P. Lieberman, B C. LeGeyt, Catherine Hou, David A. Mankoff, Robert H. Mach, Daniel A. Pryma · 2015 · Nuclear Medicine and Biology
  47. Actinium
    Harold W. Kirby, Lester R. Morss · 2007 · Springer eBooks
  48. Alpha and Proton Heavy Particles and the Bragg Peak in Therapy.
    John H. Lawrence, Cornelius A. Tobias, J L Born, John A. Linfoot, R. Kling, A. Gottschalk · 1964 · PubMed Central
  49. Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging
    Alain Paul Pecking, Dominique H. Bellet, Jean‐Louis Alberini · 2012 · Clinical & Experimental Metastasis
  50. Recurrent Bleeding in Hemorrhagic Moyamoya Disease : Prognostic Implications of the Perfusion Status
    Kyung-Il Jo, Min Soo Kim, Je Young Yeon, Jong Soo Kim, Seung‐Chyul Hong · 2016 · Journal of Korean Neurosurgical Society
  51. ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)
    Mitchell Reed Smith, Chris C. Parker, Fred Saad C, K. Miller, Bertrand F. TOMBAL, Quan Sing Ng, Martin Bögemann, Vsevolod Borisovich Matveev, Josep Maria Piulats, Luis Eduardo Rosa Zucca et al. · 2018 · Annals of Oncology
  52. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
    Huizi Keiko Li, Sumitaka Hasegawa, Nakako Izumi Nakajima, Yukie Morokoshi, Katsuyuki Minegishi, Kotaro Nagatsu · 2018 · Biochemical and Biophysical Research Communications
  53. Radioimmunotherapy With Astatine‐211 Using Chimeric Monoclonal Antibody U36 in Head and Neck Squamous Cell Carcinoma
    Junping Cheng, Tomas Ekberg, Mats Engström, Marika Nestor, Holger J. Jensen, Толмачев Владимир Максимилианович, Matti Anniko · 2007 · The Laryngoscope
  54. More α Than β for Prostate Cancer?
    Wolfgang P. Fendler, Cathy Sue Cutler · 2017 · Journal of Nuclear Medicine
  55. Long-lived Alpha Emitters in Radioimmunotherapy: The Mischievous Progeny
    George Sgouros · 2000 · Cancer Biotherapy and Radiopharmaceuticals
  56. Exploration of a F(ab′) 2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy
    Diane E. Milenic, Young‐Seung Kim, Kwamena E. Baidoo, Karen J. Wong, Rachel Barkley, Jose F. Delgado, Martin W. Brechbiel · 2018 · Cancer Biotherapy and Radiopharmaceuticals
  57. Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb
    Sophie E. Eriksson, Tom A. Bäck, Erika Elgström, Holger J. Jensen, Rune Nilsson, Sture Lindegren, Jan Tennvall · 2013 · EJNMMI Research
  58. ERA 223: A phase 3 trial of radium-223 dichloride (Ra-223) in combination with abiraterone acetate (abiraterone) and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone predominant metastatic castration-resistant prostate cancer (mCRPC).
    Matthew Raymond Smith, Chris C. Parker, Bertrand F. TOMBAL, Kurt Miller, Fred Saad C, Fang Fang, Amily Zhang, Martin Kornacker, Celestia S. Higano · 2015 · Journal of Clinical Oncology
  59. Synthesis and metal complexation properties of Ph-DTPA and Ph-TTHA: novel radionuclide chelating agents for use in nuclear medicine
    Sébastien G. Gouin, Jean‐François Gestin, Laurence Monrandeau, Fabienne Dioury, Jean Claude Meslin, David Deniaud · 2005 · Organic & Biomolecular Chemistry
  60. Role of neuroimaging in drug development
    Bikash Medhi, Shubham Misra, Pramod Avti, Pardeep Kumar, Harish Kumar, Baljinder Singh · 2014 · Reviews in the Neurosciences
  61. Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-Versagen
    Michael E. Autenrieth, Thomas D Horn, F. Kurtz, K. Nguyen, A. Morgenstern, Frank Bruchertseifer, Markus Schwaiger, M. Blechert, Christof Seidl, Reingard Senekowitsch–Schmidtke et al. · 2016 · Der Urologe
  62. Radioimmunotherapy of B-lineage non-Hodgkin's lymphoma using anti-CD19 and anti-CD20 conjugates
    Steffen Heeger, Gerd Moldenhauer, J. M. Flynn, Gerlinde Egerer, Tuomo K. Nikula, C Apostolidis, Martin W. Brechbiel, Uwe Haberkorn, Anthony Dick Ho, Rainer R. Haas · 2004 · Journal of Clinical Oncology
  63. Re: 225 Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
    Boris Alexander Hadaschik · 2016 · European Urology
  64. Targeted Alpha Therapy: The US DOE Tri-Lab (ORNL, BNL, LANL) Research Effort to Provide Accelerator-Produced 225 Ac for Radiotherapy
    Kevin D. John · 2017 · APS April Meeting Abstracts
  65. Innovative Diagnostics Enhances and Advances the Impact of In Vivo Small‐Animal Imaging in Drug Discovery and Pharmaceutical Development
    Andreas Briel · 2013
  66. Molecular Imaging Aided Improvement in Drug Discovery and Development
    Smrita Chaudhury, Bhushan L. Thakur, Subhoshree Chatterjee, Pritha Ray · 2014 · Current Biotechnology